FR2810985B1 - Peptides lineaires amphipathiques et les compositions les contenant - Google Patents

Peptides lineaires amphipathiques et les compositions les contenant

Info

Publication number
FR2810985B1
FR2810985B1 FR0008633A FR0008633A FR2810985B1 FR 2810985 B1 FR2810985 B1 FR 2810985B1 FR 0008633 A FR0008633 A FR 0008633A FR 0008633 A FR0008633 A FR 0008633A FR 2810985 B1 FR2810985 B1 FR 2810985B1
Authority
FR
France
Prior art keywords
compositions containing
linear peptides
amphipathic linear
amphipathic
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0008633A
Other languages
English (en)
Other versions
FR2810985A1 (fr
Inventor
Guillaume Drin
Jerome Gomar
Jamal Temsamani
Anthony R Rees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synt EM SA
Original Assignee
Synt EM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0008633A priority Critical patent/FR2810985B1/fr
Application filed by Synt EM SA filed Critical Synt EM SA
Priority to PCT/FR2001/002129 priority patent/WO2002002595A1/fr
Priority to EP01951760A priority patent/EP1297001A1/fr
Priority to CA002414355A priority patent/CA2414355A1/fr
Priority to JP2002507847A priority patent/JP2004517039A/ja
Priority to IL15367101A priority patent/IL153671A0/xx
Priority to AU2001272615A priority patent/AU2001272615A1/en
Publication of FR2810985A1 publication Critical patent/FR2810985A1/fr
Priority to US10/336,312 priority patent/US20030186890A1/en
Application granted granted Critical
Publication of FR2810985B1 publication Critical patent/FR2810985B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0008633A 2000-07-03 2000-07-03 Peptides lineaires amphipathiques et les compositions les contenant Expired - Fee Related FR2810985B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0008633A FR2810985B1 (fr) 2000-07-03 2000-07-03 Peptides lineaires amphipathiques et les compositions les contenant
EP01951760A EP1297001A1 (fr) 2000-07-03 2001-07-03 Peptides lineaires amphipathiques et les compositions les contenant
CA002414355A CA2414355A1 (fr) 2000-07-03 2001-07-03 Peptides lineaires amphipathiques et les compositions les contenant
JP2002507847A JP2004517039A (ja) 2000-07-03 2001-07-03 両親媒性線状ペプチド及びこれらを含有する化合物
PCT/FR2001/002129 WO2002002595A1 (fr) 2000-07-03 2001-07-03 Peptides lineaires amphipathiques et les compositions les contenant
IL15367101A IL153671A0 (en) 2000-07-03 2001-07-03 Amphipathic linear peptides and formulations containing same peptides
AU2001272615A AU2001272615A1 (en) 2000-07-03 2001-07-03 Amphipathic linear peptides and compositions containing same
US10/336,312 US20030186890A1 (en) 2000-07-03 2003-01-03 Amphipathic linear peptides and formulations containing said peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0008633A FR2810985B1 (fr) 2000-07-03 2000-07-03 Peptides lineaires amphipathiques et les compositions les contenant

Publications (2)

Publication Number Publication Date
FR2810985A1 FR2810985A1 (fr) 2002-01-04
FR2810985B1 true FR2810985B1 (fr) 2004-12-24

Family

ID=8852054

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0008633A Expired - Fee Related FR2810985B1 (fr) 2000-07-03 2000-07-03 Peptides lineaires amphipathiques et les compositions les contenant

Country Status (8)

Country Link
US (1) US20030186890A1 (fr)
EP (1) EP1297001A1 (fr)
JP (1) JP2004517039A (fr)
AU (1) AU2001272615A1 (fr)
CA (1) CA2414355A1 (fr)
FR (1) FR2810985B1 (fr)
IL (1) IL153671A0 (fr)
WO (1) WO2002002595A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830016B1 (fr) * 2001-09-27 2004-06-25 Synt Em Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau
FR2829940A1 (fr) * 2001-09-27 2003-03-28 Synt Em Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central
WO2003033021A1 (fr) * 2001-10-16 2003-04-24 Synt:Em S.A. Utilisation de vecteurs peptidiques afin d'ameliorer la reponse immunitaire aux antigenes
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
FR2840810B1 (fr) * 2002-06-18 2005-02-11 Synt Em Composition pour le transfert de molecules therapeutiques dans les poumons et leur utilisation pour le traitement des cancers du poumon et des maladies pulmonaires
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
FR2865735B1 (fr) * 2004-02-02 2006-08-11 Synt Em Inhibiteurs de l'angiogenese, compositions les contenant et leur utilisation pour le traitement des maladies liees a une deregulation de l'angiogenese
FR2865736B1 (fr) * 2004-02-02 2006-07-14 Synt Em Inhibiteurs de l'angiogenese, compositions les contenant et leur utilisation pour le traitement des maladies liees a une deregulation de l'angiogenese
WO2006116874A1 (fr) * 2005-05-05 2006-11-09 Centre For Addiction And Mental Health Compositions et methodes de modulation de la neurotransmission de la dopamine
WO2007113687A2 (fr) * 2006-03-30 2007-10-11 Diatos S.A. Conjugués de camptothécine et de peptide et compositions pharmaceutiques les contenant
GB0715809D0 (en) * 2007-08-14 2007-09-26 Univ Leuven Kath Alpha synuclein toxicity
EP2294081B1 (fr) 2008-06-12 2016-12-14 Centre For Addiction And Mental Health Compositions et procédés pour moduler l'interaction et la fonction du récepteur d1-d2 dopaminergique
EP2294082A4 (fr) * 2008-06-13 2011-07-13 Ct For Addiction And Mental Health Compositions et procédés pour moduler la fonction du récepteur nicotinique/nmda
FR2941230B1 (fr) * 2009-01-19 2011-03-18 Centre Nat Rech Scient Polypeptides d'adressage specifique a des cellules-cibles d'otx2
WO2011050152A2 (fr) * 2009-10-21 2011-04-28 The Johns Hopkins University Modification de protéines spécifiques à un site
WO2022094614A1 (fr) * 2020-10-29 2022-05-05 The Regents Of The University Of California Récepteur antigénique chimérique anti-dpp6 portant des lymphocytes t régulateurs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5580852A (en) * 1993-12-17 1996-12-03 Pioneer Hi-Bred International, Inc. Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US6015941A (en) * 1997-10-31 2000-01-18 Pioneer Hi-Bred International, Inc. Peptide derivatives of tachyplesin having antimicrobial activity

Also Published As

Publication number Publication date
EP1297001A1 (fr) 2003-04-02
FR2810985A1 (fr) 2002-01-04
JP2004517039A (ja) 2004-06-10
CA2414355A1 (fr) 2002-01-10
WO2002002595A1 (fr) 2002-01-10
WO2002002595A9 (fr) 2002-03-28
US20030186890A1 (en) 2003-10-02
AU2001272615A1 (en) 2002-01-14
IL153671A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
FR2810985B1 (fr) Peptides lineaires amphipathiques et les compositions les contenant
HUP0302893A3 (en) Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
DE60103043D1 (de) Reinigungsmittel und verflüssigungsmittel enthaltende kraftstoffzusatzzusammensetzungen und kraftstoffzusammensetzungen
HUP0302297A3 (en) Substituted thioacetamides and pharmaceutical compositions containing them
DE60105696D1 (de) Eisenhaltige Proteinzusammensetzung
DE60105565D1 (de) Stabiles und wirksames weiches feststoffprodukt
FR2805461B1 (fr) Nouveaux agents de gommage cutane et nouvelles compositions cosmetiques
PT986537E (pt) Novos compostos heteroetinilenos e composicoes farmaceuticas e cosmeticas contendo-os
MA27351A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
EE200300138A (et) Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid
HUP0500956A2 (en) Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them
FR2793682B1 (fr) Extrait de cakile maritima et composition cosmetique le contenant
DE60110503D1 (de) Immunostimulierende Zusammensetzung enthaltend Peptid und Hyaluronsäure
FR2833008B1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
GB0014206D0 (en) Protein and compositions containing it
GB0014196D0 (en) Protein and compositions containing it
GB0014215D0 (en) Protein and compositions containing it
GB0014214D0 (en) Protein and compositions containing it
GB0014212D0 (en) Protein and compositions containing it
GB0014211D0 (en) Protein and compositions containing it
GB0014209D0 (en) Protein and compositions containing it
GB0018771D0 (en) Protein and compositions containing it
GB0014208D0 (en) Protein and compositions containing it
GB0014207D0 (en) Protein and compositions containing it
GB0014204D0 (en) Protein and compositions containing it

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070330